CUTANEOUS LARGE B-CELL LYMPHOMA OF THE LEG

被引:4
|
作者
Pedraz, Javier [1 ]
Delgado, Yolanda [1 ]
Ballestero, Marta [1 ]
Fraga, Javier [2 ]
Garcia-Diez, Amaro [1 ]
Fernandez-Herrera, Jesus [1 ]
机构
[1] Hosp Univ Princesa, Serv Dermatol, Diego Leon,62, Madrid 28006, Spain
[2] Hosp Univ Princesa, Serv Anatomia Patol, Madrid, Spain
来源
ACTAS DERMO-SIFILIOGRAFICAS | 2005年 / 96卷 / 04期
关键词
large B-cell lymphoma of the leg; rituximab;
D O I
10.1016/S0001-7310(05)73076-3
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Large B-cell lymphoma of the leg (LBCLL) accounts for 2 % of primary cutaneous lymphomas, and the EORTC considers it to be of intermediate prognosis. It usually presents in elderly patients, and manifests clinically as erythematous nodules or tumors, often unilateral, on the lower third of the legs. On rare occasions, it presents with extracutaneous dissemination. We present the case of a 77-year-old male who consulted his physician because of an asymptomatic indurated erythematous papule which had appeared one month earlier on his left leg and had quickly and progressively increased in size. Concurrently, other similar lesions had been appearing on the thigh and back of the same leg. Histological analysis detected a large cell lymphoid infiltrate positive for CD20 and bcl-2 throughout the dermis. The extension study was normal. The patient was treated with an intravenous infusion of rituximab for four consecutive weeks, with full remission of the lesions.
引用
收藏
页码:237 / 240
页数:4
相关论文
共 50 条
  • [31] Diagnosis and treatment of diffuse large B-cell lymphoma
    Mey, Ulrich
    Hitz, Felicitas
    Lohri, Andreas
    Pederiva, Stefanie
    Taverna, Christian
    Tzankov, Alexander
    Meier, Oliver
    Yeow, Karen
    Renner, Christoph
    SWISS MEDICAL WEEKLY, 2012, 142
  • [32] Loncastuximab tesirine for diffuse large B-cell lymphoma
    Zurko, J.
    Hamadani, M.
    DRUGS OF TODAY, 2021, 57 (12) : 733 - 743
  • [33] Primary diffuse large B-cell lymphoma of the stomach
    Ferreri, Andres J. M.
    Montalban, Carlos
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 63 (01) : 65 - 71
  • [34] Diffuse large B-cell lymphoma: An institutional analysis
    Gogia, Ajay
    Das, Chandan K.
    Kumar, Lalit
    Sharma, Atul
    Tiwari, Akash
    Sharma, M. C.
    Mallick, Soumya
    SOUTH ASIAN JOURNAL OF CANCER, 2018, 7 (03) : 200 - 202
  • [35] CNS prophylaxis for diffuse large B-cell lymphoma
    Eyre, Toby A.
    Savage, Kerry J.
    Cheah, Chan Y.
    El-Galaly, Tarec C.
    Lewis, Katharine L.
    McKay, Pamela
    Wilson, Matthew R.
    Evens, Andrew M.
    Bobillo, Sabela
    Villa, Diego
    Maurer, Matthew J.
    Cwynarski, Kate
    Ferreri, Andres
    LANCET ONCOLOGY, 2022, 23 (09): : E416 - E426
  • [36] Antibody and immunotherapy in diffuse large B-cell lymphoma
    Barraclough, Allison
    Hawkes, Eliza A.
    SEMINARS IN HEMATOLOGY, 2023, 60 (05) : 338 - 345
  • [37] Intravascular Large B-Cell Lymphoma: A Diagnostic Dilemma
    Roy, Arya Mariam
    Pandey, Yadav
    Middleton, Derek
    Broadfoot, Brannon
    Sasapu, Appalanaidu
    Veeraputhiran, Muthu
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (07)
  • [38] Primary Diffuse Large B-Cell Lymphoma of the Bladder
    Hayashi, Akinori
    Miyakawa, Yoshitaka
    Bokuda, Kota
    Kimura, Toshinori
    Nakashima, Emiko
    Irie, Rie
    Sugiura, Hitoshi
    Suzuki, Takahiro
    Ohsone, Yasuo
    Akizuki, Satoshi
    INTERNAL MEDICINE, 2009, 48 (16) : 1403 - 1406
  • [39] Rituximab and chemotherapy in diffuse large B-cell lymphoma
    Sonet, Anne
    Bosly, Andre
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (06) : 719 - 726
  • [40] Pembrolizumab for the treatment of diffuse large B-cell lymphoma
    Sheikh, Semira
    Kuruvilla, John
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (11) : 1119 - 1126